UCHL1 and Parkinson disease: Therefore, these inhibitors may constitute new tools to investigate further the implication of UCH-L1 in Parkinson’s disease and evaluate whether UCH-L1 inhibition favors the clearance of α-synuclein aggregates in neurons.